Skip to content

The multi-center clinical study of perioperative electroacupuncture on intestinal barrier to enhance recovery after colorectal cancer surgery

The multi-center clinical study of perioperative electroacupuncture on intestinal barrier to enhance recovery after colorectal cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018146
Enrollment
Unknown
Registered
2018-09-01
Start date
2018-10-31
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon-rectal cancer

Interventions

Group 2:Systemic intravenous anesthesia + perioperative electropuncture
Group 1:Systemic intravenous anesthesia

Sponsors

Yueyang Hospital of integrated traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-75 years old men and women; 2. American Standands Association(ASA) anesthesia grading I-III; 3. Colorectal cancer, meeting the operative conditons and laparoscopic surgery are required, no other serious complications; 4. The function of heart,lung, liver, kidney and coagulation are good enough to get through abdominal surgery, no immune system diseases; 5. The subjects are voluntary to participate this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients with distant metastasis or extensive dissemination in the abdominal cavity; 2. The patients with perforation or obstruction; 3. The patients who were perfomed operations along meridians; 4. The patients with shin infections at the acupoints; 5. The patients with nerve injuries at upper or lower extremities; 6. The patients who had participated other clinical trials in four weeks; 7. The patients who can not coordinate the plan, such as voice difficulties and infectious disease.

Design outcomes

Primary

MeasureTime frame
anal exhaust time;D-lactose;diamine-oxidase;endotoxin;

Secondary

MeasureTime frame
CD cell subsets;adrenocorticotropic hormone;

Countries

China

Contacts

Public ContactGu Qunhao

Yueyang Hospital of Integrated Chinese and Western Medicine

guqh9199@163.com+86 18930568793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026